A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Leveraging Mammography to Identify and Engage Women at Risk for Lung Cancer in Lung Cancer Screening

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04848961

Enrollment

Registered

2021-04-19

Start date

2021-04-09

Completion date

2027-04-09

Last updated

2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

mammogram, LDCT screening, BiRADS 1, BiRADS 2, 21-103, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communications and LungTalk, a web-based (accessed through the Internet) health communication tool that uses text, audio, video, and animation to increase awareness and knowledge about lung cancer screening. This study will focus on women who have recently received a screening mammogram.

Interventions

BEHAVIORALLungTalk

MSK developed LungTalk, a novel computer-tailored health communication and decision support tool to (1) increase awareness and knowledge about lung screening; (2) decrease perceived barriers to screening based upon misinformation; and (3) increase screening rates.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days * Age 50-80 years * ≥ 20-pack-year smoking history of combustible cigarettes as per self report * Women who currently smoke or quit within past 15 years as per self report * Lung screening naïve as per self-report

Exclusion criteria

* Lung cancer diagnosis * Chest CT within the last 12 months

Design outcomes

Primary

Measure	Time frame	Description
Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening	6 months	Develop a proactive digital outreach and engagement strategy to identify breast screening patients who are eligible for lung screening.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORTali Amir, MD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026